CARDIFF, Calif. (AP) _ Viracta Therapeutics, Inc. (VIRX) on Wednesday reported a loss of $79.2 million in its first quarter.
On a per-share basis, the Cardiff, California-based company said it had a loss of $5.22. Earnings, adjusted for non-recurring costs, were 38 cents per share.
The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 2 cents per share.
Sunesis shares have risen 73% since the beginning of the year. The stock has fallen 42% in the last 12 months.
The Associated Press